staceywhite, Author at European Medical Journal - Page 103 of 195

EMJ

Assessing Vitality in Neonates Can Predict Risk of Cerebral Palsy and Epilepsy

THE RISK of being diagnosed with cerebral palsy or epilepsy can be predicted by the score a neonate receives on the Apgar scale, according to research…

Missing Protein Could Explain Cases of Unexplained Infertility

INFERTILITY may occur when a specific protein is not present in eggs, according to a study by researchers at the University of California, California…

Exercise Can Boost Fat Metabolism and the Body’s Immune System

EXERCISE can improve fat metabolism and strengthen the immune system through the same mechanism previously shown to give beneficial effects to the brain…

Researchers Discover How a Form of Skin Cancer Evades Drug Treatment

NEW targets in the drug development for basal cell carcinoma have been discovered by researchers from Stanford University, California, USA. This…

New Technology Shown to Successfully Accelerate Wound Healing

AN INNOVATIVE method of accelerating wound healing has been developed by researchers from Uppsala University, Uppsala, Sweden and SLU, Missouri, USA…

Blood Vessel Scans Far Quicker Using New Method

MAGNETIC resonance angiography (MRA) scans can be completed in around 5 minutes using a new method developed by a team from UCLA, California…

Community Pharmacists Reduce Pressures and Improve Patient Care

PRESSURES on GP practices can be significantly alleviated by the use of community pharmacists in surgeries, according to a new NHS England report…

Heart Ageing Could be Reversed Through Exercise

DAMAGE to the heart caused by a sedentary lifestyle can be reversed by exercise, provided it is initiated early and undertaken regularly, suggest the…

Depression is Underdiagnosed in Elderly Aortic Valve Replacement Patients

DEPRESSION is a common symptom in elderly patients with cardiovascular disease. Now, a new study performed by researchers at the Jewish General Hospital…

Eslicarbazepine Acetate Shown to be Effective in Treating Newly-Diagnosed Focal Epilepsy Patients

ONCE-DAILY eslicarbazepine acetate (Zebinix®, Eisai, Tokyo, Japan) is non-inferior to the current standard of care, twice-daily controlled-released…